Patents by Inventor Suzanne E. McKenna

Suzanne E. McKenna has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ApoE analogs and methods for their use
    Patent number: 8288335
    Abstract: Novel ApoE peptide derivatives and ApoE-protein transduction domain conjugates are disclosed which are useful for treating disorders including CNS inflammation, traumatic brain injury, inflammatory bowel disease (also known as Crohn's Disease or ulcerative colitis), cerebral ischemia, atherosclerosis, sepsis, multiple sclerosis and arthritic diseases, Alzheimer's Disease and other brain disorders. The invention encompasses methods for protecting subjects having undergone irradiation or radiotherapy by administration of ApoE or at least one ApoE mimetic peptide.
    Type: Grant
    Filed: April 28, 2011
    Date of Patent: October 16, 2012
    Assignee: Cognosei, Inc.
    Inventors: Michael P. Vitek, Suzanne E. McKenna
  • APOE ANALOGS AND METHODS FOR THEIR USE
    Publication number: 20110306550
    Abstract: Novel ApoE peptide derivatives and ApoE-protein transduction domain conjugates are disclosed which are useful for treating disorders including CNS inflammation, traumatic brain injury, inflammatory bowel disease (also known as Crohn's Disease or ulcerative colitis), cerebral ischemia, atherosclerosis, sepsis, multiple sclerosis and arthritic diseases, Alzheimer's Disease and other brain disorders. The invention encompasses methods for protecting subjects having undergone irradiation or radiotherapy by administration of ApoE or at least one ApoE mimetic peptide.
    Type: Application
    Filed: April 28, 2011
    Publication date: December 15, 2011
    Applicant: Cognosci, Inc.
    Inventors: Michael P. VITEK, Suzanne E. MCKENNA, Christopher R. SELF
  • APO E analogs and methods for their use
    Patent number: 7947645
    Abstract: Novel ApoE-protein transduction domain conjugates are disclosed which are useful for treating disorders including CNS inflammation, traumatic brain injury, cerebral ischema, Alzheimer's Disease and other brain disorders.
    Type: Grant
    Filed: September 2, 2005
    Date of Patent: May 24, 2011
    Assignee: Cognosci, Inc.
    Inventors: Michael P. Vitek, Suzanne E. McKenna, Christopher R. Self